RICARDO ALKMIM TEIXEIRA

(Fonte: Lattes)
Índice h a partir de 2011
7
Projetos de Pesquisa
Unidades Organizacionais

Resultados de Busca

Agora exibindo 1 - 8 de 8
  • conferenceObject
    Role of impedance cardiography in predicting clinical near-term outcomes of patients with cardiac resynchronization therapy
    (2014) MARTINELLI FILHO, MMartino; PEIXOTO, G. L.; SIQUEIRA, S. F.; LENSI, M. M.; TRINDADE, R. H. L.; NISHIOKA, S. A. D.; TEIXEIRA, R. A.; PEDROSA, A. A. A.; COSTA, R.
  • article 11 Citação(ões) na Scopus
    SBC Guideline on the Diagnosis and Treatment of Patients with Cardiomyopathy of Chagas Disease-2023
    (2023) MARIN-NETO, Jose Antonio; JR, Anis Rassi; OLIVEIRA, Glaucia Maria Moraes; CORREIA, Luis Claudio Lemos; RAMOS JUNIOR, Alberto Novaes; LUQUETTI, Alejandro Ostermayer; HASSLOCHER-MORENA, Alejandro Marcel; SOUSA, Andrea Silvestre de; PAOLA, Angelo Amato Vincenzo de; SOUSA, Antonio Carlos Sobral; RIBEIRO, Antonio Luiz Pinho; CORREIA FILHO, Dalmo; SOUZA, Dilma do Socorro Moraes de; CUNHA-NETO, Edecio; RAMIRES, Felix Jose Alvarez; BACAL, Fernando; NUNES, Maria do Carmo Pereira; MARTINELLI FILHO, Martino; SCANAVACCA, Maurici Ibrahim; SARAIVA, Roberto Magalhaes; OLIVEIRA JUNIOR, Wilson Alves de; LORGA-FILHO, Adalberto Menezes; GUIMARAES, Adriana de Jesus Benevides de Almeida; BRAGA, Adriana Lopes Latado; OLIVEIRA, Adriana Sarmento de; SARABANDA, Alvaro Valentim Lima; PINTO, Ana Yece das Neves; CARMO, Andre Assis Lopes do; SCHMIDT, Andre; COSTA, Andrea Rodrigues da; IANNI, Barbara Maria; MARKMAN FILHO, Brivaldo; ROCHITT, Carlos Eduardo; MACEDO, Carolina The; MADY, Charles; CHEVILLARD, Christophe; VIRGENS, Claudio Marcelo Bittencourt das; CASTRO, Cleudson Nery de; BRITTO, Constanca Felicia De Paoli de Carvalho; PISANI, Cristiano; RASSI, Daniel do Carmo; SOBRAL FILHO, Dario Celestino; ALMEIDA, Dirceu Rodrigues de; BOCCHI, Edimar Alcides; MESQUITA, Evandro Tinoco; MENDES, Fernanda de Souza Nogueira Sardinha; GONDIM, Francisca Tatiana Pereira; SILVA, Gilberto Marcelo Sperandio da; PEIXOTO, Giselle de Lima; LIMA, Gustavo Glotz de; VELOSO, Henrique Horta; MOREIRA, Henrique Turin; LOPES, Hugo Bellotti; PINTO, Ibraim Masciarelli Francisco; FERREIRA, Joao Marcos Bemfica Barbosa; NUNES, Joao Paulo Silva; BARRETO-FILHO, Jose Augusto Soares; SARAIVA, Jose Francisco Kerr; LANNES-VIEIRA, Joseli; OLIVEIRA, Joselina Luzia Menezes; ARMAGANIJAN, Luciana Vidal; MARTINS, Luiz Claudio; SANGENIS, Luiz Henrique Conde; BARBOSA, Marco Paulo Tomaz; ALMEIDA-SANTOS, Marcos Antonio; SIMOES, Marcos Vinicius; YASUDA, Maria Aparecida Shikanai; MOREIRA, Maria da Consolacao Vieira; HIGUCHI, Maria de Lourdes; MONTEIRO, Maria Rita de Cassia Costa; MEDIANO, Mauro Felippe Felix; LIMA, Mayara Maia; OLIVEIRA, Maykon Tavares de; ROMANO, Minna Moreira Dias; ARAUJO, Nadjar Nitz Silva Lociks de; MEDEIROS, Paulo de Tarso Jorge; ALVES, Renato Vieira; TEIXEIRA, Ricardo Alkmim; PEDROSA, Roberto Coury; ARAS JUNIOR, Roque; TORRES, Rosalia Morais; POVOA, Rui Manoel dos Santos; RASSI, Sergio Gabriel; ALVES, Silvia Marinho Martins; TAVARES, Suelene Brito do Nascimento; PALMEIRA, Swamy Lima; SILVA JUNIOR, Telemaco Luiz da; RODRIGUES, Thiago da Rocha; MADRINI JUNIOR, Vagner; BRANT, Veruska Maia da Costa; DUTRA, Walderez Ornelas; DIAS, Joao Carlos Pinto
  • article 11 Citação(ões) na Scopus
    Acute cholestatic hepatitis caused by amoxicillin/clavulanate
    (2013) BERALDO, Daniel Oliveira; MELO, Joanderson Fernandes; BONFIM, Alexandre Vidal; TEIXEIRA, Andrei Alkmim; TEIXEIRA, Ricardo Alkmim; DUARTE, Andre Loyola
    Amoxicillin/clavulanate is a synthetic penicillin that is currently commonly used, especially for the treatment of respiratory and cutaneous infections. In general, it is a well-tolerated oral antibiotic. However, amoxicillin/clavulanate can cause adverse effects, mainly cutaneous, gastrointestinal, hepatic and hematologic, in some cases. Presented here is a case report of a 63-year-old male patient who developed cholestatic hepatitis after recent use of amoxicillin/clavulanate. After 6 wk of prolonged use of the drug, he began to show signs of cholestatic icterus and developed severe hyperbilirubinemia (total bilirubin > 300 mg/L). Diagnostic investigation was conducted by ultrasonography of the upper abdomen, serum tests for infection history, laboratory screening of autoimmune diseases, nuclear magnetic resonance (NMR) of the abdomen with bile duct-NMR and transcutaneous liver biopsy guided by ultrasound. The duration of disease was approximately 4 mo, with complete resolution of symptoms and laboratory changes at the end of that time period. Specific treatment was not instituted, only a combination of anti-emetic (metoclopramide) and cholestyramine for pruritus.
  • article 44 Citação(ões) na Scopus
    Evidence for cardiac safety and antiarrhythmic potential of chloroquine in systemic lupus erythematosus
    (2014) TEIXEIRA, Ricardo Alkmim; BORBA, Eduardo F.; PEDROSA, Anisio; NISHIOKA, Silvana; VIANA, Vilma S. T.; RAMIRES, Jose A.; KALIL-FILHO, Roberto; BONFA, Eloisa; MARTINELLI FILHO, Martino
    To perform a comprehensive evaluation of heart rhythm disorders and the influence of disease/therapy factors in a large systemic lupus erythematosus (SLE) cohort. Three hundred and seventeen consecutive patients of an ongoing electronic database protocol were evaluated by resting electrocardiogram and 142 were randomly selected for 24 h Holter monitoring for arrhythmia and conduction disturbances. The mean age was 40.2 +/- 12.1 years and disease duration was11.4 +/- 8.1 years. Chloroquine (CQ) therapy was identified in 69.7% with a mean use of 8.5 +/- 6.7 years. Electrocardiogram abnormalities were detected in 66 patients (20.8%): prolonged QTc/QTd (14.2%); bundle-branch block (2.5%); and atrioventricular block (AVB) (1.6%). Age was associated with AVB (P = 0.029) and prolonged QTc/QTd (P = 0.039) whereas anti-Ro/SS-A and Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) scores were not (P > 0.05). Chloroquine was negatively associated with AVB (P = 0.01) as was its longer use (6.1 +/- 6.9 vs. 1.0 +/- 2.5 years, P = 0.018). Time of CQ use was related with the absence of AVB [odds ratio (OR) = 0.103; 95% confidence interval (CI) = 0.011-0.934, P = 0.043] in multiple logistic regression. Holter monitoring revealed abnormalities in 121 patients (85.2%): supraventricular ectopies (63.4%) and tachyarrhythmia (18.3%); ventricular ectopies (45.8%). Atrial tachycardia/fibrillation (AT/AF) were associated with shorter CQ duration (7.05 +/- 7.99 vs. 3.63 +/- 5.02 years, P = 0.043) with a trend to less CQ use (P = 0.054), and older age (P < 0.001). Predictors of AT/AF in multiple logistic regression were age (OR = 1.115; 95% CI = 1.059-1.174, P < 0.001) and anti-Ro/SS-A (OR = 0.172; 95% CI = 0.047-0.629, P = 0.008). Chloroquine seems to play a protective role in the unexpected high rate of cardiac arrhythmias and conduction disturbances observed in SLE. Further studies are necessary to determine if this antiarrhythmic effect is due to the disease control or a direct effect of the drug.
  • article 37 Citação(ões) na Scopus
    II BRAZILIAN GUIDELINES OF ATRIAL FIBRILLATION Introduction
    (2016) MAGALHAES, L. P.; FIGUEIREDO, M. J. O.; CINTRA, F. D.; SAAD, E. B.; KUNIYISHI, R. R.; TEIXEIRA, R. A.; LORGA FILHO, A. M.; D'AVILA, A.; V, A. A. de Paola; KALIL, C. A.; MOREIRA, D. A. R.; SOBRAL FILHO, D. C.; STERNICK, E. B.; DARRIEUX, F. C. C.; FENELON, G.; LIMA, G. G.; ATIE, J.; MATEOS, J. C. P.; MOREIRA, J. M.; VASCONCELOS, J. T. M.; I, L. Zimerman; SILVA, L. R. L.; SILVA, M. A.; I, M. Scanavacca; SOUZA, O. F.
  • conferenceObject
    Left ventricular remodeling behavior of patients with Chagas cardiomyopathy and pacemaker in a long-term follow-up
    (2014) PEIXOTO, G.; MARTINELLI, M.; SIQUEIRA, S. F.; MADIA, R. O.; LENSI, M. M.; NISHIOKA, S. A. D.; TEIXEIRA, R. A.; PEDROSA, A. A. A.; COSTA, R.
  • conferenceObject
    Predictors of death in patients with diabetes mellitus and ischemic left ventricular dysfunction
    (2014) MARTINELLI FILHO, M.; ROCHA, M. S.; PEIXOTO, G. L.; SIQUEIRA, S. F.; NAKAHIRA, E. S.; HUEB, W. A.; CESAR, L. A. M.; HUEB, T. O.; TEIXEIRA, R. A.; COSTA, R.
  • article
    III DIRECTIVES OF THE BRAZILIAN SOCIETY OF CARDIOLOGY ON ANALYSIS AND ISSUANCE OF ELECTROCARDIOGRAPHIC REPORTS Introduction
    (2016) PASTORE, C. A.; PINHO, J. A.; PINHO, C.; SAMESIMA, N.; PEREIRA-FILHO, H. G.; KRUSE, J. C. L.; PAIXAO, A.; PEREZ-RIERA, A. R.; RIBEIRO, A. L.; OLIVEIRA, C. A. R.; GOMES, C. I. G.; KAISER, E.; GALVAO, F.; DARRIEUX, F. C. C.; FRANCA, F. F. A. C.; FEITOSA-FILHO, G.; GERMINIANI, H.; AZIZ, J. L.; LEAL, M. G.; MOLINA, M.; OLIVEIRA, N. M. T.; OLIVEIRA, P. A.; SANCHES, P. C. R.; ALMEIDA, R. M.; BARBOSA, R.; TEIXEIRA, R. A.; DOUGLAS, R. A. G.; GUNDIM, R. S.; ATANES, S. M.